Delivery Order SPE2DB22D1202-SPE2DB25FUSL0

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.52 Firm Fixed Price Delivery Order contract is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,614.14 firm-fixed-price delivery order is for the supply of the pharmaceutical product Verquvo 5 mg tablets. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,501.47 firm fixed-price delivery order is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.82 firm fixed-price delivery order is for the supply of VERQUVO 5 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The $1,091.70 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 90S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.35 firm fixed-price delivery order is for the supply of 30-tablet packages of the medication Verquvo 5 mg. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
The federal contract award summarized in the provided information is for the delivery of VERQUVO 2.5 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor for this $28,684.71 firm fixed price delivery order contract is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024, with no set-aside requirements....
This federal contract award, valued at $1,354.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $4,396.10 firm fixed-price contract is for the delivery of VERQUVO 10 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The award has an ultimate completion date of November 19, 2024 and was issued on November 18, 2024. This contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,443.38 Firm Fixed Price Delivery Order is for the supply of VABOMERE 2 gram vials, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUSL0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,704.60 Firm Fixed Price Delivery Order contract is for the supply of the medication VERQUVO 2.5 MG TABLET 30S. The contract has an ultimate completion date of February 11, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/12/25, 10:25 AM